Zobrazeno 1 - 10
of 396
pro vyhledávání: '"Karpefors M"'
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 14, Pp 1-11 (2021)
Jonathan Corren,1 Martin Karpefors,2 Åsa Hellqvist,3 Jane R Parnes,4 Gene Colice5 1Departments of Medicine and Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; 2Data Science and AI, AstraZeneca, Gothenburg
Externí odkaz:
https://doaj.org/article/85c2e1a80c26407ca56b966e3aea265a
Autor:
Buendia R; Data Science, Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: Ruben.Buendia@astrazeneca.com., Karpefors M; Data Science, Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Folkvaljon F; Patient Centered Science, BioPharmaceuticals Business, AstraZeneca, Gothenburg, Sweden., Hunter R; Regulatory, Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Luton, UK., Sillen H; Digital Health R&D, AstraZeneca, Gothenburg, Sweden., Luu L; Digital Health R&D, AstraZeneca, Gaithersburg, MD, US., Docherty K; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Cowie MR; Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, US.
Publikováno v:
Journal of cardiac failure [J Card Fail] 2024 May; Vol. 30 (5), pp. 703-716. Date of Electronic Publication: 2024 Mar 05.
Autor:
Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; The George Institute for Global Health, Sydney, New South Wales, Australia., Jongs N; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Schloemer P; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany., Little DJ; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Brinker M; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany., Tasto C; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany., Karpefors M; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wheeler DC; The George Institute for Global Health, Sydney, New South Wales, Australia.; Department of Renal Medicine, University College London, London, United Kingdom., Bakris G; Department of Medicine, University of Chicago Medicine, Chicago, Illinois., Perkovic V; The George Institute for Global Health, Sydney, New South Wales, Australia.; Faculty of Medicine & Health, University New South Wales, Sydney, New South Wales, Australia., Nkulikiyinka R; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany., Rossert J; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2023 Dec 01; Vol. 34 (12), pp. 2025-2038. Date of Electronic Publication: 2023 Oct 24.
Autor:
Little DJ; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Schloemer P; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany., Jongs N; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brinker M; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany., Karpefors M; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Tasto C; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany., Rethemeier N; Pharmaceuticals, Research and Development, Bayer AG, Wuppertal, Germany., Frison L; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Nkulikiyinka R; Pharmaceuticals, Research and Development, Bayer AG, Berlin, Germany., Rossert J; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; The George Institute for Global Health, Sydney, New South Wales, Australia.
Publikováno v:
Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2023 Dec 01; Vol. 34 (12), pp. 1928-1935. Date of Electronic Publication: 2023 Oct 09.
Autor:
Karpefors M; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Gasparyan SB; Late Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2023 Feb; Vol. 20 (1), pp. 84-88. Date of Electronic Publication: 2022 Nov 14.
Publikováno v:
Medical & Biological Engineering & Computing. Mar2007, Vol. 45 Issue 3, p275-281. 7p. 2 Diagrams, 4 Graphs.
Publikováno v:
Diseases of the Esophagus. Sep2011, Vol. 24 Issue 7, p462-469. 8p. 1 Color Photograph, 1 Diagram, 1 Chart, 3 Graphs.
Autor:
Karpefors M; Advanced Analytics Centre, AstraZeneca R&D, Gothenburg, Sweden., Weatherall J; Advanced Analytics Centre, AstraZeneca R&D, Macclesfield, UK.
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA [J Am Med Inform Assoc] 2018 Aug 01; Vol. 25 (8), pp. 1069-1073.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gillett, Alexandra C.1,2 (AUTHOR) alexandra.a.gillett@kcl.ac.uk, Hagenaars, Saskia P.1,2 (AUTHOR), Handley, Dale1 (AUTHOR), Casanova, Francesco3 (AUTHOR), Young, Katherine G.3 (AUTHOR), Green, Harry3 (AUTHOR), Lewis, Cathryn M.1,2,4 (AUTHOR), Tyrrell, Jess3 (AUTHOR)
Publikováno v:
BMC Medicine. 5/29/2024, Vol. 22 Issue 1, p1-15. 15p.